Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Curtiss

Showing results (51-60 of 351) with videos related to

Pageof 36
Sort By:
Journal of Managed Care Pharmacy : JMCP|November 14, 2003
Statistical significance versus practical significanceFrederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|November 14, 2003
Prevalence and costs of atopic dermatitisFrederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|November 14, 2003
Cost-effective use of Cox-2 drugs and NSAIDsFrederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|November 14, 2003
Actual prescribing versus guidelinesFrederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|November 14, 2003
Hypertension, prescription drug copayments, and drug therapy adherenceFrederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|November 14, 2003
Pressure on pharmacy benefit managers for disclosure and demonstration of value--rebates and drug benefit cost savingsFrederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|November 14, 2003
Finding the truth about health care cost drivers--price versus utilization factorsFrederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|December 11, 2003
Evidence-based medicine, practice guidelines, and disease managementFrederic R Curtiss
American Journal of Hospital Pharmacy|September 1, 1990
Managed care: the second generationF R Curtiss
Employee Benefits Journal|November 6, 1987
Pharmacy services and managed care: TPAs, PPOs and DUM (drug utilization management)F R Curtiss
Pageof 36

Showing results (51-60 of 351) with videos related to

Sort By:
Pageof 36
Journal of Managed Care Pharmacy : JMCP|November 14, 2003
Statistical significance versus practical significanceFrederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|November 14, 2003
Prevalence and costs of atopic dermatitisFrederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|November 14, 2003
Cost-effective use of Cox-2 drugs and NSAIDsFrederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|November 14, 2003
Actual prescribing versus guidelinesFrederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|November 14, 2003
Hypertension, prescription drug copayments, and drug therapy adherenceFrederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|November 14, 2003
Pressure on pharmacy benefit managers for disclosure and demonstration of value--rebates and drug benefit cost savingsFrederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|November 14, 2003
Finding the truth about health care cost drivers--price versus utilization factorsFrederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|December 11, 2003
Evidence-based medicine, practice guidelines, and disease managementFrederic R Curtiss
American Journal of Hospital Pharmacy|September 1, 1990
Managed care: the second generationF R Curtiss
Employee Benefits Journal|November 6, 1987
Pharmacy services and managed care: TPAs, PPOs and DUM (drug utilization management)F R Curtiss
Pageof 36